We're making updates and relaunching soon. Get notified

Straight answers about GLP-1 medications

Plain-language guides on dosing, side effects, costs, and what to look for in a provider.

Relaunching Soon

  • Relaunching as an independent GLP-1 guide
  • Get notified when we relaunch
  • We only ask for your email
Get Started

One email to confirm. Unsubscribe anytime.

Semaglutide Constipation: Causes, Timeline, and Evidence-Based Management Strategies

You are constipated. Your bowel movements have slowed, stools are harder, and you are uncomfortable. This is one of the most common side effects of GLP-1 medications, and the good news is that for many people it is manageable once you understand what is actually helping. Here is what is happening and what tends to help.

Why GLP-1 medications cause constipation: the mechanism

Constipation on GLP-1 medications is not random. It results directly from how the medication works throughout your digestive system.

GLP-1 receptors are distributed along your entire gastrointestinal tract, including in the large intestine (colon). When you take a GLP-1 medication, it slows the movement of food not just through your stomach, but through your entire digestive system. Food and waste materials move through your colon more slowly than normal.

At the same time, reduced appetite from the medication means you are consuming less food overall. This means less volume of material is moving through your colon in the first place. Fewer calories and less mass means less bulk to stimulate bowel movements.

On top of that, many people experience reduced thirst when their appetite is suppressed. You may naturally drink less water without realizing it. Dehydration is one of the most common drivers of constipation. When there is less fluid in your system, stool becomes harder and moves more slowly.

Together, these mechanisms create the perfect conditions for constipation: slower gut transit time, less material moving through, and less hydration. All three factors need to be addressed.

Constipation data: how common and timeline

In clinical trials, constipation is one of the most frequently reported side effects of GLP-1 medications, along with nausea, diarrhea, and vomiting.

In the pooled placebo-controlled weight-reduction trials summarized in the FDA prescribing information for Wegovy (semaglutide), 24% of adults taking 2.4 mg reported constipation, compared with 11% on placebo[3]. In the pooled trials summarized in the FDA prescribing information for Zepbound (tirzepatide), 17%, 14%, and 11% of adults taking 5 mg, 10 mg, and 15 mg reported constipation, compared with 5% on placebo[4].

The key finding: in the STEP 1 trial of semaglutide[1] and the SURMOUNT-1 trial of tirzepatide[2], most gastrointestinal side effects were mild to moderate. Trial results describe study participants and are not a prediction for any individual; results vary.

24% vs 11%
Adults reporting constipation on semaglutide 2.4 mg vs placebo (Wegovy prescribing information)
11-17% vs 5%
Adults reporting constipation on tirzepatide 5-15 mg vs placebo (Zepbound prescribing information)
Mild to moderate
Typical severity of most GI side effects in STEP 1 and SURMOUNT-1
Postmarketing
Both labels list ileus, intestinal obstruction, and severe constipation including fecal impaction among postmarketing reports

When constipation is most likely to occur

Constipation can start in the first weeks of GLP-1 treatment. In trials and the FDA labels, gastrointestinal side effects were reported most often while starting the medication and during dose increases[2][3][4], so it may come back or worsen when your dose goes up. For many people it then eases as the body adjusts and hydration and fiber intake increase, though how long that takes varies.

Some people have persistent constipation at higher maintenance doses. It does not necessarily mean something is wrong, but it is worth raising with your provider. It often means your body needs ongoing support with hydration and fiber to maintain regular bowel movements, and many people can find a routine that works.

What makes constipation worse

Certain behaviors amplify constipation, especially in the early weeks.

Dehydration: This is one of the biggest drivers of constipation on GLP-1 medications. When appetite decreases, many people automatically drink less water, coffee, or other fluids. A common target is 8-10 glasses of water per day, even if you do not feel thirsty, unless a provider has told you to limit fluids.

Low fiber intake: While you are eating less overall, do not accidentally cut out the foods that help bowel movements. Fruits, vegetables, whole grains, and legumes contain fiber that stimulates the colon. If you are eating much less food, you need to be intentional about including these.

Suddenly adding large amounts of fiber: Do not compensate for constipation by suddenly doubling your fiber intake. This can cause bloating, gas, and abdominal discomfort. Increase fiber gradually over 1-2 weeks.

Inactivity: Movement, especially gentle walking, helps bowel motility. Sitting or lying down most of the day worsens constipation. Even 15-20 minutes of walking per day can make a difference.

Ignoring the urge to have a bowel movement: When the urge comes, respond to it. Delaying creates a cycle of reinforced constipation.

Certain medications: If you take iron supplements, antihistamines, or certain pain medications, these can worsen constipation independently of GLP-1 effects. Talk to your provider if you take other medications.

What actually helps: evidence-informed strategies

The most impactful changes address the root causes: hydration, fiber, and movement.

Hydration is the foundation: Drink water consistently throughout the day. A common target is 8-10 glasses of plain water daily, unless a provider has told you to limit fluids. You can also count herbal tea, broths, or electrolyte drinks. Do not rely on this single approach alone, but it is one of the most important steps.

Gradually increase dietary fiber: Include more fruits (apples, berries, pears), vegetables (broccoli, carrots, leafy greens), whole grains, and legumes (beans, lentils, chickpeas). The key word is gradually. Add a bit more each day over 1-2 weeks rather than overhauling your diet at once. This helps prevent gas and bloating. Our guide to fiber and constipation on a GLP-1 covers high-fiber foods for a small appetite.

Psyllium husk supplements: If dietary fiber is not enough, psyllium husk supplements are a common option. Mix with water and drink it, then drink additional water after. Psyllium works by absorbing water and forming bulk in the stool, making it easier to pass.

Stool softeners: Docusate sodium is an over-the-counter stool softener that makes stool softer and easier to pass. It is gentle and is meant for short-term use, generally up to about a week per the package directions, as you adjust to increased hydration and fiber.

Osmotic laxatives: Polyethylene glycol is an over-the-counter osmotic laxative that draws water into the stool. It is intended for occasional, short-term use per the package directions and should not become your daily routine without discussing it with your provider first.

Stimulant laxatives for acute relief: Senna and bisacodyl can be used for occasional relief when you have not had a bowel movement for 2-3 days. These should not be used daily as your primary approach unless your provider advises it.

Magnesium supplements: Some people find that magnesium citrate or magnesium oxide helps with bowel regularity. Talk to your provider before starting, especially if you have kidney problems or take other medications.

Movement: Even light walking, 15-30 minutes daily, can help bowel motility. Yoga or stretching can also stimulate digestion.

Massage: Gentle abdominal massage in a clockwise direction (following the path of the colon) can help move stool along. This is low-risk and some people find it helpful.

What makes constipation worse

  • Dehydration and low fluid intake
  • Suddenly cutting fiber-rich foods
  • Sudden large additions of fiber
  • Lack of movement or exercise
  • Ignoring the urge to have a bowel movement
  • Higher medication doses

What actually helps with constipation

  • Drinking enough water through the day
  • Gradually increasing fiber intake
  • Fiber supplements (psyllium husk)
  • Stool softeners (docusate) short-term
  • Osmotic laxatives (polyethylene glycol) for occasional use
  • Regular movement and walking

What does not help (and what to avoid)

Eating even less because you are eating less: You might think cutting food more dramatically will help, but it actually makes constipation worse by reducing the volume of material moving through your colon. Eating balanced, nutritious meals is important.

Daily stimulant laxative use: While occasional senna or bisacodyl can help in a pinch, daily use is not the goal unless your provider recommends it. The aim is to restore normal bowel function with hydration, fiber, and movement.

Ignoring it and hoping it resolves on its own: Constipation often improves with hydration and fiber, but ignoring it for weeks can lead to complications like fecal impaction. If you have not had a bowel movement in 3 days despite hydration and fiber efforts, contact your provider.

When to contact your provider

Mild constipation in the first weeks is common. But certain situations warrant a call to your provider.

Get medical care the same day: If you have severe or worsening abdominal pain, or no bowel movement together with vomiting, a swollen belly, or being unable to pass gas, get medical care promptly. Those can be signs of a blocked bowel. The FDA prescribing information for semaglutide (Wegovy) and tirzepatide (Zepbound) lists ileus, intestinal obstruction, and severe constipation including fecal impaction among postmarketing reports; because these reports are voluntary, the labels note that how often they happen cannot be reliably estimated[3][4].

No bowel movement for more than 3 days: Even with increased water and fiber intake, if you have not had a bowel movement in more than 3 days, contact your provider. This may indicate a need for medication support or dose adjustment.

Severe abdominal pain or extreme bloating: Mild discomfort can accompany constipation, but severe pain is not typical and could indicate impaction or another condition requiring evaluation.

Blood in stool: Small amounts of blood can occur from straining or internal hemorrhoids related to constipation. However, any bleeding should be discussed with your provider to rule out other causes.

Signs of fecal impaction: If you experience severe constipation with overflow (small amounts of liquid stool leaking), severe abdominal distention, loss of appetite, or intense straining, this could indicate impaction. Contact your provider immediately.

Constipation that does not improve after 2-3 weeks: If bowel frequency and comfort are not improving within a couple of weeks of increasing hydration and fiber, contact your provider. Your dose escalation schedule or medication choice may need adjustment.

Constipation worsening significantly at each dose increase: Some constipation is common when your dose increases. If it is becoming severe enough to significantly impact your quality of life, talk to your provider about slowing the escalation schedule.

The realistic timeline: what to expect

There is no fixed schedule, and the trials did not report a week-by-week course for constipation. Here is a general pattern many people describe; yours may differ.

First weeks: Bowel movements may become less frequent. This is the time to be proactive about hydration and fiber.

As habits settle: If you are drinking enough water and eating adequate fiber-rich foods, you may start noticing improvement, and bowel movements may move back toward your usual frequency.

Over the following weeks: For many people, constipation eases once hydration and fiber strategies are consistent. This is more likely if you were not dehydrated or low in fiber before starting the medication.

At dose increases: Gastrointestinal side effects were reported most often during dose escalation[2][3][4], so constipation may return for a while after your dose increases. Knowing which strategies work for you can help you respond sooner.

At maintenance dose: Once you reach your maintenance dose and stay there, constipation may lessen for many people. Some people continue to need higher-than-normal water intake and dietary fiber, and this becomes part of their baseline routine.

Some people have persistent mild constipation at therapeutic doses. For them, ongoing hydration and fiber management becomes part of their routine. This is not a failure of the medication. It simply means your GI system is working with the medication’s effect on transit time, and many people manage it with the strategies outlined above and their provider’s guidance.

What a proper weight loss program should include

A program’s job is not just tracking weight loss. Look for one where the licensed provider pays attention to side effects like constipation and makes it clear how to reach them when a symptom needs attention.

Before prescribing, a licensed provider should review factors in your health history that might make constipation more likely, such as prior bowel issues, a low-fiber diet, or other medications. Some programs include nutrition guidance or coaching on hydration and fiber; others leave it to you. If that support matters to you, ask before you choose a program who provides it and whether it costs extra.

If constipation is affecting your quality of life, the provider you choose can recommend interventions matched to your situation, and dose adjustment or slower escalation may be options. Treatment decisions belong with that provider.


Citations

[1] Wilding JPH, et al. “Once-Weekly Semaglutide in Adults with Overweight or Obesity.” N Engl J Med 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/

[2] Jastreboff AM, et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” N Engl J Med 2022;387(3):205-216. https://pubmed.ncbi.nlm.nih.gov/35658024/

[3] U.S. Food and Drug Administration. WEGOVY (semaglutide) injection and tablets prescribing information. Revised 06/2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215256s025lbl.pdf

[4] U.S. Food and Drug Administration. ZEPBOUND (tirzepatide) injection prescribing information. Revised 08/2026. https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/217806Orig1s041correctedlbl.pdf

Important: This content is for general education and is not medical advice. Talk with a licensed provider about your situation. Transformation Health is an independent publisher. It does not provide medical care, prescribe, or sell medication. Compounded semaglutide and tirzepatide are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality. They are not the same as brand-name products such as Wegovy or Zepbound and may differ in formulation, purity, and potency. Results vary. Trial results describe study participants and are not a prediction for any individual. Check with your provider or pharmacist before starting a laxative or supplement while on medication, and get medical care promptly for severe abdominal pain or vomiting. Wegovy is a trademark of Novo Nordisk A/S. Zepbound is a trademark of Eli Lilly and Company. Transformation Health is not affiliated with or endorsed by these companies.

FAQ

Frequently Asked Questions

Everything you need to know about getting started.

Still have questions?

Contact our support team
How common is constipation on GLP-1 medications?
Constipation is one of the most commonly reported side effects of GLP-1 medications. In the pooled weight-reduction trials summarized in the Wegovy prescribing information, 24% of adults taking semaglutide 2.4 mg reported constipation, compared with 11% on placebo. In the Zepbound prescribing information, 17%, 14%, and 11% of adults taking tirzepatide 5 mg, 10 mg, and 15 mg reported constipation, compared with 5% on placebo. In the STEP 1 and SURMOUNT-1 trials, most gastrointestinal side effects were mild to moderate. Results vary from person to person.
Why do GLP-1 medications cause constipation?
GLP-1 medications slow the movement of food through your entire digestive tract, not just your stomach. This slowing affects the large intestine as well, which can slow bowel movements. Additionally, reduced appetite means less material moving through your colon overall. Dehydration from reduced fluid intake can also contribute. All of these factors combined can cause constipation, especially in the first few weeks of treatment.
When does constipation typically start and resolve?
Constipation can start in the first weeks of treatment or come back at a dose increase. In trials and the FDA labels, gastrointestinal side effects were reported most often while starting the medication and during dose increases. How long constipation lasts varies; for many people it eases as the body adjusts and once hydration and fiber habits are in place. Some people, particularly at higher doses, have longer-lasting constipation that needs ongoing management with their provider.
What is the difference between constipation and gastroparesis?
Constipation is infrequent bowel movements or difficulty passing stool and is very common on GLP-1 medications. Gastroparesis is a serious condition where the stomach cannot empty properly and presents with severe nausea, vomiting, abdominal pain, and inability to keep food down. Gastroparesis is much less common than constipation on GLP-1 medications. If you experience severe abdominal pain, persistent vomiting, or inability to eat, contact your provider immediately or get medical care the same day.
Can I use laxatives while on GLP-1 medication?
Often, yes, but the type matters, so check with your provider or pharmacist first. Stool softeners (docusate sodium) and osmotic laxatives (polyethylene glycol) are commonly used for short-term relief; follow the package directions, which generally limit use to about a week unless a provider advises otherwise. Stimulant laxatives (senna, bisacodyl) can be used for occasional relief but should not become your daily routine. Hydration and dietary fiber are the usual first-line approach. If constipation persists beyond 2-3 weeks despite these changes, talk to your provider about which laxative option is appropriate for you.

We're relaunching soon

We're relaunching as an independent GLP-1 guide. Leave your email and we'll let you know when your free custom report is ready.

Get Started

About This Site: Disclosures

Who We Are

transformationhealth.com is a website operated by Amerigo Health LLC. Transformation Health is an independent publisher. It does not provide medical care, prescribe, or sell medication, and does not give medical advice. Providers and programs mentioned on this site are independent third parties.

How We Make Money

Transformation Health does not accept payment from providers.

Educational Purpose

This content is for general education and is not medical advice. Talk with a licensed provider about your situation. Results vary. Trial results describe study participants and are not a prediction for any individual.

Compounded Medications

Compounded medications are not FDA-approved. The FDA does not review them for safety, effectiveness, or quality. Compounded semaglutide and tirzepatide are not the same as brand-name products such as Wegovy, Ozempic, Zepbound, or Mounjaro. They may differ in formulation, purity, and potency.

Trademarks

Wegovy and Ozempic are trademarks of Novo Nordisk A/S. Zepbound and Mounjaro are trademarks of Eli Lilly and Company. Transformation Health is not affiliated with or endorsed by these companies.